Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on February 2, 2021. The filing addresses a specific regulatory event regarding the company's listing status on the Nasdaq Capital Market. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock price compliance rather than financial performance.
Material Changes
The primary material event is the resolution of a Nasdaq listing deficiency:
- Prior Status: On November 5, 2020, the company received notice of non-compliance with Nasdaq Listing Rule 5550(a)(2) due to a closing bid price below $1.00 per share for 30 consecutive business days.
- Resolution: On February 2, 2021, Nasdaq confirmed the company regained compliance. The closing bid price was at least $1.00 per share for 10 consecutive business days (January 19, 2021, to February 1, 2021).
- Outcome: The compliance matter is now closed, and the company is no longer under the 180-day compliance period that was set to expire on May 4, 2021.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of future risks beyond the immediate resolution of the listing status. The document confirms the removal of the specific risk associated with potential delisting due to low bid price.
Investor Verification Checklist
- Verify the current trading status of NanoVibronix, Inc. (NAOV) on the Nasdaq Capital Market.
- Confirm the company's current stock price relative to the $1.00 minimum bid requirement.
- Review subsequent filings to ensure no new listing deficiencies have arisen since February 2, 2021.
- Clarify the discrepancy between the request metadata (Envue Medical, Inc.) and the filing registrant (NanoVibronix, Inc.).